Use of Chimeric Antigen Receptor T Cells as a Potential Therapeutic for Glioblastoma

Neurosurgery. 2017 May 1;80(5):N33-N34. doi: 10.1093/neuros/nyx105.
No abstract available

Publication types

  • Comment

MeSH terms

  • Brain Neoplasms
  • Glioblastoma*
  • Humans
  • Receptors, Antigen
  • T-Lymphocytes*

Substances

  • Receptors, Antigen